JPS6312064B2 - - Google Patents

Info

Publication number
JPS6312064B2
JPS6312064B2 JP55009174A JP917480A JPS6312064B2 JP S6312064 B2 JPS6312064 B2 JP S6312064B2 JP 55009174 A JP55009174 A JP 55009174A JP 917480 A JP917480 A JP 917480A JP S6312064 B2 JPS6312064 B2 JP S6312064B2
Authority
JP
Japan
Prior art keywords
compound according
formula
moranoline
compound
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55009174A
Other languages
English (en)
Japanese (ja)
Other versions
JPS56108768A (en
Inventor
Shingo Matsumura
Hiroshi Enomoto
Yoshiaki Aoyanagi
Yoshiaki Yoshikuni
Masahiro Yagi
Kohei Kura
Ichiro Shirahase
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Priority to JP917480A priority Critical patent/JPS56108768A/ja
Priority to GB8100186A priority patent/GB2067990B/en
Priority to IT8147592A priority patent/IT1209839B/it
Priority to FR8101519A priority patent/FR2478094A1/fr
Priority to CH54681A priority patent/CH643831A5/de
Priority to DE19813102768 priority patent/DE3102768A1/de
Priority to US06/247,884 priority patent/US4336374A/en
Publication of JPS56108768A publication Critical patent/JPS56108768A/ja
Publication of JPS6312064B2 publication Critical patent/JPS6312064B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP917480A 1980-01-28 1980-01-28 Cinnamylmoranoline derivative Granted JPS56108768A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP917480A JPS56108768A (en) 1980-01-28 1980-01-28 Cinnamylmoranoline derivative
GB8100186A GB2067990B (en) 1980-01-28 1981-01-06 Cinnamyl moranoline derivatives
IT8147592A IT1209839B (it) 1980-01-28 1981-01-19 Derivati della cinnamil moranolina
FR8101519A FR2478094A1 (fr) 1980-01-28 1981-01-27 Derives de cinnamylmoranoline a substitution ammonio, a activite d'inhibition de l'augmentation de niveau de sucre dans le sang
CH54681A CH643831A5 (de) 1980-01-28 1981-01-28 Cinnamyl-moranolin-derivate.
DE19813102768 DE3102768A1 (de) 1980-01-28 1981-01-28 "cinnamylmoranolinderivate"
US06/247,884 US4336374A (en) 1980-01-28 1981-03-26 Quaternary ammonium substituted N-cinnamylpiperidines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP917480A JPS56108768A (en) 1980-01-28 1980-01-28 Cinnamylmoranoline derivative

Publications (2)

Publication Number Publication Date
JPS56108768A JPS56108768A (en) 1981-08-28
JPS6312064B2 true JPS6312064B2 (en, 2012) 1988-03-17

Family

ID=11713206

Family Applications (1)

Application Number Title Priority Date Filing Date
JP917480A Granted JPS56108768A (en) 1980-01-28 1980-01-28 Cinnamylmoranoline derivative

Country Status (7)

Country Link
US (1) US4336374A (en, 2012)
JP (1) JPS56108768A (en, 2012)
CH (1) CH643831A5 (en, 2012)
DE (1) DE3102768A1 (en, 2012)
FR (1) FR2478094A1 (en, 2012)
GB (1) GB2067990B (en, 2012)
IT (1) IT1209839B (en, 2012)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2181729B (en) * 1985-10-12 1990-04-04 Nippon Shinyaku Co Ltd Glucosylmoranoline derivatives and production thereof
JPS62242692A (ja) * 1986-04-15 1987-10-23 Nippon Shinyaku Co Ltd モラノリン誘導体の製造法
JP2504000B2 (ja) * 1986-09-02 1996-06-05 日本新薬株式会社 グルコシルモラノリン誘導体
US5536732A (en) * 1990-04-27 1996-07-16 Merrell Pharmaceuticals Inc. N-derivatives of 1-deoxy nojirimycin
US5252587A (en) * 1990-04-27 1993-10-12 Merrell Dow Pharmaceuticals, Inc. N-derivatives of 1-deoxy nojirimycin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
DE2830469A1 (de) * 1978-07-11 1980-01-24 Bayer Ag Herstellung von l-desoxy-nojirimycin und n-substituierten derivaten

Also Published As

Publication number Publication date
CH643831A5 (de) 1984-06-29
DE3102768A1 (de) 1982-01-07
US4336374A (en) 1982-06-22
JPS56108768A (en) 1981-08-28
IT8147592A0 (it) 1981-01-19
IT1209839B (it) 1989-08-30
GB2067990A (en) 1981-08-05
GB2067990B (en) 1984-07-25
FR2478094A1 (fr) 1981-09-18
FR2478094B1 (en, 2012) 1983-09-09

Similar Documents

Publication Publication Date Title
SU820659A3 (ru) Способ получени производных 4-амино- 5-АлКилСульфОНилОАНизАМидОВ, иХ СОлЕй,ОКиСЕй, лЕВО- и пРАВОВРАщАющиХизОМЕРОВ /иХ ВАРиАНТы/
JPS5943459B2 (ja) Ｎ−アルキルピペリジン誘導体
JPS6089474A (ja) モルフイナン誘導体，その製造方法，及び該化合物を含有する抗腫瘍剤
EP0047536B1 (en) Substituted propylamines
SU1356960A3 (ru) Способ получени производных пиридазина
JPH01503786A (ja) プロスタグランジン誘導体，それらの製法及びそれらを含有する医薬組成物
DE3419009A1 (de) Neue substituierte bis(4-aminophenyl)sulfone, ihre herstellung und ihre verwendung als arzneimittel
JPS6216942B2 (en, 2012)
JPS6312063B2 (en, 2012)
JPS6312064B2 (en, 2012)
US4794197A (en) All-cis-1,3,5-triamino-2,4,6,-cyclohexanetriol derivatives, their use, processes for their preparation and pharmaceutical preparations containing them
CN107522647B (zh) 含吲哚基团的α-氨基酰胺衍生物及其医药用途
CS274287B2 (en) Method of azoniaspironortropanol esters production
JPS6183193A (ja) カテコールアミン化合物のｅ／ｏ―ホスフェートエステル，その製法およびそれを含有する薬剤組成物
EP0063084B1 (fr) Dérivés de phénéthanolamine, leur préparation et leur application en thérapeutique
JPS6338344B2 (en, 2012)
JPS6139306B2 (en, 2012)
DE69836331T2 (de) 2-sulfamoylbenzoesäure-derivate
JPS6026387B2 (ja) シンナミルモラノリン誘導体
CA3196777A1 (en) Amino-combretastatin derivative and use thereof
US4143143A (en) Substituted imidazo[5,1-a]isoquinolines
CA2379370A1 (en) Carboxylic acid derivatives of 3-hydroxy-4-oxo-1,4-dihydropyridine as iron chelators
JPS5943946B2 (ja) Ｎ−アルケニルモラノリン誘導体
EP0113910A1 (en) Isocarbostyril derivatives, processes for their preparation and pharmaceutical compositions containing them
US4126625A (en) Certain 5-substituted-3-methyl-2-benzofuran acetic acids